Aspire Biopharma Holdings, Inc. Common Stock (ASBP) Stock Price
ASBPStock
$8.27−98.81%52W
Market Cap$11.60M
P/E—
PEG Ratio—
Div yield—
Beta0.16
ASBP Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-94.45%
Price vs S&P 500 (4W)4.75%
VGM Score40.34
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ASBPAspire Biopharma Holdings, Inc. Common Stock | — | — | C | $8.27 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Aspire Biopharma Holdings, Inc. Common Stock
Aspire Biopharma Holdings Inc develops nanotechnology-based drug delivery systems designed to improve medication absorption while reducing gastrointestinal exposure. The company's platform targets pain and inflammation management, with applications to opioid-related therapeutics. Its proprietary delivery mechanisms aim to enhance the efficacy and safety profiles of pharmaceutical compounds.